Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 3294
Gene Symbol: HSD17B2
HSD17B2
0.370 Biomarker disease BEFREE The pooled sensitivity and specificity in endometriosis were .79 (.71, .86) and .89 (.82, .94) for aromatase, .30 (.18, .46) and .80 (.65, .90) for human chorionic gonadotropin/luteinizing hormone receptor, .75 (.66, .83) and .47 (.34, .60) for estrogen receptor (ER)-α, .65 (.56, .74) and .68 (.55, .80) for ER-β, .45 (.38-.52) and .92 (.85-.97) for serum prolactin, .69 (.51, .83) and .30 (.16, .49) for estrogen sulfotransferase, and .73 (.60-.84) and .48 (.33-.63) for 17β-hydroxysteroid dehydrogenase type 2 (17βHSD2). 30965114 2020
Entrez Id: 3294
Gene Symbol: HSD17B2
HSD17B2
0.370 Biomarker disease BEFREE These alterations in retinoid signaling may help explain the decidualization defects and deficient estradiol inactivation (via HSD17B2) seen in endometriosis. 28592664 2017
Entrez Id: 3294
Gene Symbol: HSD17B2
HSD17B2
0.370 AlteredExpression disease BEFREE Our results thus suggest that in peritoneal endometriosis the beneficial effects of these progestins can be explained by lower HSD17B1 and higher HSD17B2 mRNA and protein levels, which lead to reduced local E2 biosynthesis. 22878119 2012
Entrez Id: 3294
Gene Symbol: HSD17B2
HSD17B2
0.370 Biomarker disease CTD_human Aldo-keto reductases AKR1C1, AKR1C2 and AKR1C3 may enhance progesterone metabolism in ovarian endometriosis. 21232532 2011
Entrez Id: 3294
Gene Symbol: HSD17B2
HSD17B2
0.370 Biomarker disease BEFREE In 8-Br-cAMP-treated hESF from eutopic endometrium of women with endometriosis, the balance in estradiol (E2) and P4 biosynthetic and metabolizing enzymes is disturbed (decreased HSD3B1 and HSD17B2, and increased HSD17B1 and aromatase), with the equilibrium being shifted towards an E2-enriched milieu. 18815356 2009
Entrez Id: 3294
Gene Symbol: HSD17B2
HSD17B2
0.370 Biomarker disease CTD_human In 8-Br-cAMP-treated hESF from eutopic endometrium of women with endometriosis, the balance in estradiol (E2) and P4 biosynthetic and metabolizing enzymes is disturbed (decreased HSD3B1 and HSD17B2, and increased HSD17B1 and aromatase), with the equilibrium being shifted towards an E2-enriched milieu. 18815356 2009
Entrez Id: 3294
Gene Symbol: HSD17B2
HSD17B2
0.370 AlteredExpression disease LHGDN Expression of 17beta-hydroxysteroid dehydrogenase type 2 in pelvic endometriosis. 17505937 2007
Entrez Id: 3294
Gene Symbol: HSD17B2
HSD17B2
0.370 AlteredExpression disease LHGDN Analysis of aromatase and 17beta-hydroxysteroid dehydrogenase type 2 messenger ribonucleic acid expression in deep endometriosis and eutopic endometrium using laser capture microdissection. 16595205 2006
Entrez Id: 3294
Gene Symbol: HSD17B2
HSD17B2
0.370 AlteredExpression disease BEFREE Moreover, estrogen metabolism, including the expression pattern of aromatase and the regulation of 17 beta-hydroxysteroid dehydrogenase type 2 (an enzyme responsible for the inactivation of estradiol to estrone), is altered in the eutopic endometrium of women with endometriosis, adenomyosis, and/or leiomyomas compared to that in the eutopic endometrium of women without disease. 12650711 2002